Health

In a recent study conducted by ARS Pharmaceuticals, the president and CEO, Richard Lowenthal, highlighted the importance of testing medications under extreme temperatures. Lowenthal mentioned that many parents admitted to leaving the EpiPen in the car due to fear of it getting hot. This resulted in the need to analyze the effects of temperature on
0 Comments
UnitedHealth Group (UHG) recently reported a staggering revenue of nearly $400 billion in 2023, a figure that few could comprehend. Their profits of $22.4 billion and fourth-quarter earnings of $5.5 billion paint a picture of financial success that is almost unimaginable. With revenue increasing by 14.6% to $371.6 billion, UHG’s financial performance has reached levels
0 Comments
The study conducted by Jugnoo Rahi, MBBS, PhD, MSc, and colleagues at University College London found an interesting association between childhood amblyopia (lazy eye) and adult cardiometabolic disorders. The research, published in eClinicalMedicine, analyzed data from the U.K. Biobank and revealed that individuals with persistent amblyopia were at a higher risk for conditions such as
0 Comments
The fight against tuberculosis (TB) has been ongoing for decades, and the emergence of drug-resistant strains has complicated the situation even further. In a recent phase II randomized controlled trial, a novel combination of alpibectir-ethionamide has shown promising results in terms of bactericidal activity and tolerability. This could potentially provide a new avenue in the
0 Comments
Recent research has shown that there is a potential connection between essential tremor and dementia. A prospective cohort study found that over 5 years, the cumulative prevalence of dementia in individuals with essential tremor was 18.5%. This is a significant finding, as it highlights the heightened risk of developing dementia for those with essential tremor.
0 Comments
The use of ambient artificial intelligence (AI) in healthcare to listen to clinician-patient conversations and process information is a promising development. However, there are significant concerns regarding security and privacy issues that need to be addressed. The potential for breaches of sensitive information is a major worry that could have serious implications for patient confidentiality.
0 Comments
The latest data from the CDC’s IVY and VISION networks shed light on the protection offered by recently updated COVID vaccines against severe virus-related outcomes in immunocompetent adults. The study conducted from September 2023 to January 2024 revealed that the vaccine effectiveness (VE) against COVID-related emergency department or urgent care visits was determined to be
0 Comments
A study conducted by Jeffrey Cohen, MD, at the Cleveland Clinic in Ohio, presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) forum, highlighted the stable or improved disease activity measures for patients with relapsing multiple sclerosis (RMS) undergoing 7 to 8 years of continuous treatment with ozanimod (Zeposia). Regardless of
0 Comments
The correlation between obesity and the progression of multiple sclerosis (MS) is a topic of significant interest in the medical community. A recent prospective cohort study presented at the ACTRIMS Forum 2024 shed light on the detrimental effects of obesity on MS patients. The findings, discussed by Lars Alfredsson, PhD, highlighted the association between obesity
0 Comments
The latest reports on the effectiveness of flu shots in the ongoing winter flu season in the United States have been released. According to health officials at a recent CDC vaccines meeting, the vaccines have shown an effectiveness rate of around 40% in preventing adults from falling ill to the extent of requiring medical attention.
0 Comments